OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial

Springer Science and Business Media LLC - Tập 6 - Trang 1-1 - 2009
JR Currier1, M De Souza2, S Ratto-Kim1, R Paris2, V Nguay1, J Cox3, P Earl4, B Moss4, S Sriplienchan2, P Thongcharoen2, J Kim1, M Robb1, N Michael1, M Marovich1
1Department of Vaccine Research and Development, Military HIV Research Program, Rockville, USA
2AFRIMS, Bangkok, Thailand
3IAVI, Rockville, USA
4NIAID, Bethesda, USA